Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
Zimmer
>
Amedica and Zimmer soon to be one
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6011765"]Below, just a few excerpts from a long list is to answer the above quotes:</p><ul> <li>The <b>stock weakness</b> gives legitimacy to the <b>contrived negative blogs</b>. The idea is to <b>create fear and uncertainty among investors</b> by making <b>all news events appear to be negatives</b> and to <b>fabricate new issues</b> that the shorts hope will <b><span style="color: #ff0000">demoralize investors</span></b>.</li> </ul><p> <ul> <li>There are a number of bloggers who participate in these attacks. Many of these bloggers appear to work together and <b>coordinate their negative attacks</b>. It is striking that many of <b>these people have connections to one another</b>. Many of them were trained at a well-known blogging site that was founded by hedge fund people.</li> </ul><p> <ul> <li>The situation quickly escalated. In the rebuttal, the blogger <b><span style="color: #ff0000">accused</span></b> me of being stupid, <b>deceitful and <span style="color: #ff0000">being paid by the Company</span> to write positive comments</b>.</li> </ul><p> <ul> <li>The blogger was <b>indifferent to truth and actually would make up information that was factually incorrect</b>. When made aware that the information was wrong, he/she would<b> ignore it and even repeat it in later blogs</b>.</li> </ul><p></p><p>From here:</p><p><br /></p><p><a href="https://smithonstocks.com/illegal-naked-short-selling-appears-to-lie-at-the-heart-of-an-extensive-stock-manipulation-scheme/" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://smithonstocks.com/illegal-naked-short-selling-appears-to-lie-at-the-heart-of-an-extensive-stock-manipulation-scheme/" rel="nofollow">https://smithonstocks.com/illegal-naked-short-selling-appears-to-lie-at-the-heart-of-an-extensive-stock-manipulation-scheme/</a></p><p><br /></p><p><a href="http://counterfeitingstock.com/CounterfeitingStock.html" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://counterfeitingstock.com/CounterfeitingStock.html" rel="nofollow">http://counterfeitingstock.com/CounterfeitingStock.html</a></p><p><br /></p><p>Know their methods:</p><p><br /></p><p>Blame the Management! Attack the stock!</p><p><br /></p><p>Attack the FACT poster; the researcher (Boston), trying to discredit his hard work! Trying to MUTE him! Because he is threatening their interests!</p><p><br /></p><p>Spread negative misinformation about the tiny company (Amedica)... with superior technologies that being bought out soon by a bigger medical device company (Zimmer)...based on so many pieces of evidence.</p><p><br /></p><p>etc...</p><p><br /></p><p>Now, to answer the quotes regarding, personnel & product development connections:</p><p><br /></p><p>[QUOTE="anonymous,...]Currently, a few Zimmer VPs at Amedica:</p><p><br /></p><p><a href="https://www.linkedin.com/in/ryanjlong/" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.linkedin.com/in/ryanjlong/" rel="nofollow">https://www.linkedin.com/in/ryanjlong/</a></p><p><br /></p><p><a href="https://www.linkedin.com/in/jamey-rottman/" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.linkedin.com/in/jamey-rottman/" rel="nofollow">https://www.linkedin.com/in/jamey-rottman/</a></p><p><br /></p><p><a href="https://www.linkedin.com/in/dana-lyons-a23b9550/" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.linkedin.com/in/dana-lyons-a23b9550/" rel="nofollow">https://www.linkedin.com/in/dana-lyons-a23b9550/</a>[/QUOTE]</p><p><br /></p><p><br /></p><p>[QUOTE="anonymous,...]The Board of Directors of <b>Orthopaedic Synergy, Inc</b>. ("OSI") whose subsidiary companies include <b>OMNIlife science</b>®, Inc., Enztec, Ltd., and Praxim, SA, have elected two experienced directors to their Board. <b>Guy Mayer,</b></p><p><br /></p><p><a href="https://www.prnewswire.com/news-releases/orthopaedic-synergy-inc-announces-key-additions-to-the-board-of-directors-208198531.html" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.prnewswire.com/news-releases/orthopaedic-synergy-inc-announces-key-additions-to-the-board-of-directors-208198531.html" rel="nofollow">https://www.prnewswire.com/news-rel...ions-to-the-board-of-directors-208198531.html</a></p><p><br /></p><p>President of the Orthopedics Implant Division - <a href="https://www.zoominfo.com/c/zimmer-inc/43303663" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.zoominfo.com/c/zimmer-inc/43303663" rel="nofollow">Zimmer Inc</a></p><p><br /></p><p><a href="https://www.zoominfo.com/p/Guy-Mayer/382663" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.zoominfo.com/p/Guy-Mayer/382663" rel="nofollow">https://www.zoominfo.com/p/Guy-Mayer/382663</a></p><p><br /></p><p>Late December 2013 - Early 2014, OSI helped them to design <b>prototype of femoral heads</b> to initiate the <b>biomechanical testing with a strategic partne</b>r</p><p><br /></p><p>Per below blog, even Amedica Spine Fusion CASCADE clinical trial was supervised by Zimmer Surgeons:</p><p><br /></p><p><a href="https://amedicablog.wordpress.com/2017/09/12/zimmer-amedica-connections-via-personnel/" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://amedicablog.wordpress.com/2017/09/12/zimmer-amedica-connections-via-personnel/" rel="nofollow">https://amedicablog.wordpress.com/2017/09/12/zimmer-amedica-connections-via-personnel/</a> [/QUOTE]</p><p><br /></p><p>In addition to personnel & product development connections, <b>Zimmer & Amedica</b> have <b>connections via business partners</b> as well:</p><p><br /></p><p><a href="https://seekingalpha.com/article/4110015-amedica-amda-presents-ladenburg-thalmann-2017-healthcare-conference-slideshow" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://seekingalpha.com/article/4110015-amedica-amda-presents-ladenburg-thalmann-2017-healthcare-conference-slideshow" rel="nofollow">https://seekingalpha.com/article/4110015-amedica-amda-presents-ladenburg-thalmann-2017-healthcare-conference-slideshow</a></p><p><br /></p><p>On slide 27/30, NGK billion-dollar company partner with Amedica and:</p><p><br /></p><p><a href="http://www.jmdm.co.jp/eng/corporate/partners" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.jmdm.co.jp/eng/corporate/partners" rel="nofollow">http://www.jmdm.co.jp/eng/corporate/partners</a></p><p><br /></p><p>and...From NGK & Japan Medical Dynamic Marketing Inc business alliance:</p><p><br /></p><blockquote><p>Notice of Capital and <b>Business Alliance with Japan Medical Dynamic Marketing Inc. and Acquisition of Stock Shares</b> (Equity Method Affiliate)</p></blockquote><p><br /></p><p><a href="https://www.ngkntk.co.jp/english/news/upload/20160420_e.pdf" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.ngkntk.co.jp/english/news/upload/20160420_e.pdf" rel="nofollow">https://www.ngkntk.co.jp/english/news/upload/20160420_e.pdf</a></p><p><br /></p><p>and....since 2009, Zimmer & JMDM are parnters!</p><p><br /></p><blockquote><p>In <b>November 2009</b>, we concluded a <b>joint sales agreement with Zimmer K.K</b>. to further strengthen our product lineup and promote joint sales, thus expanding our market share at the same time.</p></blockquote><p><br /></p><p><a href="http://www.jmdm.co.jp/eng/products" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.jmdm.co.jp/eng/products" rel="nofollow">http://www.jmdm.co.jp/eng/products</a></p><p><br /></p><p>Furthermore, </p><p><br /></p><blockquote><p>On <b>September 22, 2017, Zimmer Biomet G.K</b>. (the “Borrower”), a wholly-owned subsidiary of Zimmer Biomet Holdings, Inc. (the “Company”), entered into (i) a <b>Term Loan Agreement</b> (the “New Term Loan Agreement”) with <b>Sumitomo Mitsui Banking Corporation (“SMBC”), for a new <span style="color: #ff0000">¥21.3 billion</span> term loan</b>,</p></blockquote><p><br /></p><p><a href="https://www.sec.gov/Archives/edgar/data/1136869/000119312517297866/d464265d8k.htm" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.sec.gov/Archives/edgar/data/1136869/000119312517297866/d464265d8k.htm" rel="nofollow">https://www.sec.gov/Archives/edgar/data/1136869/000119312517297866/d464265d8k.htm</a></p><p><br /></p><p>The loan amount is around $189 millions USD.</p><p><br /></p><p>What is cooking in Japan? Why such a big loan? Some forms of business preparations to profit in Japan Market!</p><p><br /></p><p>Coincidentally, or jointly planned, whatever you put it, Amedica's latest business update:</p><p><br /></p><blockquote><p><b>Progress toward regulatory clearance in <span style="color: #ff0000">Japan</span></b>.</p><p><br /></p></blockquote><p><a href="https://investors.amedica.com/press-releases/detail/113/amedica-provides-business-update" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://investors.amedica.com/press-releases/detail/113/amedica-provides-business-update" rel="nofollow">https://investors.amedica.com/press-releases/detail/113/amedica-provides-business-update</a></p><p><br /></p><p>&</p><p><br /></p><p>Even new Spine HQ:</p><p><br /></p><p><a href="http://ozarch.com/2017/10/zimmer-biomet-spine-opens-new-headquarters-westminster-colorado/" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://ozarch.com/2017/10/zimmer-biomet-spine-opens-new-headquarters-westminster-colorado/" rel="nofollow">http://ozarch.com/2017/10/zimmer-biomet-spine-opens-new-headquarters-westminster-colorado/</a></p><p><br /></p><p>Amedica has mature Spine products & other products are being developed too. See all the clicks between both?</p><p><br /></p><p><b>Zimmer Spine business has tons of room to grow, ranking #5 in the industry</b> (look at page 25):</p><p><br /></p><p><a href="https://www.sec.gov/Archives/edgar/data/1136869/000119312517065632/d285470d10k.htm" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.sec.gov/Archives/edgar/data/1136869/000119312517065632/d285470d10k.htm" rel="nofollow">https://www.sec.gov/Archives/edgar/data/1136869/000119312517065632/d285470d10k.htm</a></p><p><br /></p><p>and the <b>job openings at the new Spine HQ</b> (expanding):</p><p><br /></p><p><a href="https://www.indeed.com/jobs?q=Zimmer+Biomet&rbl=Westminster,+CO&jlid=6f64b78298d21bb1" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.indeed.com/jobs?q=Zimmer+Biomet&rbl=Westminster,+CO&jlid=6f64b78298d21bb1" rel="nofollow">https://www.indeed.com/jobs?q=Zimmer+Biomet&rbl=Westminster,+CO&jlid=6f64b78298d21bb1</a></p><p><br /></p><p>& Of course...</p><p><br /></p><p>Most importantly, Zimmer's CEO <b>Hanson's own words</b>:</p><p><br /></p><blockquote><p>"In terms of our innovation capabilities, <b>Zimmer Biomet</b> is <b><span style="color: #ff0000">uniquely positioned to leverage platform technologies</span></b> across our entire portfolio, including <b><span style="color: #ff0000">advanced proprietary materials</span></b> and surgical robotics applications. As a company, we plan to build on this foundation. We will have an <b>unwavering emphasis</b> on <b><span style="color: #ff0000">patient safety and quality excellence</span></b>, creating an engaged and innovative workplace and working to position the company to deliver <b><span style="color: #ff0000">top quartile total shareholder returns.</span></b>"</p><p><br /></p><p>"That said, based on everything I've learned, <b>I am more <span style="color: #ff0000">confident than ever</span> that this business is going to turn around</b>. Although the <b>pacing may not be what you expected or hoped for</b>, I'm <b><span style="color: #ff0000">100% confident</span> that the <span style="color: #ff0000">end game</span></b> is going to be something you're <b><span style="color: #ff0000">going to be very happy</span></b> about. So thanks so much. I appreciate you joining the call today. I'm looking forward <b>to connecting with you between now and earnings call</b>, I’m sure, <b><span style="color: #ff0000">through various events</span></b>, but really looking forward to connecting on the <b><span style="color: #ff0000">first quarter earnings call</span></b> as we <b><span style="color: #ff0000">give guidance for 2018</span></b>. Thanks so much."</p><p><br /></p><p><a href="https://seekingalpha.com/article/4141232-zimmer-biomets-zbh-ceo-bryan-hanson-q4-2017-results-earnings-call-transcript?part=single" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://seekingalpha.com/article/4141232-zimmer-biomets-zbh-ceo-bryan-hanson-q4-2017-results-earnings-call-transcript?part=single" rel="nofollow">https://seekingalpha.com/article/4141232-zimmer-biomets-zbh-ceo-bryan-hanson-q4-2017-results-earnings-call-transcript?part=single</a></p><p><br /></p></blockquote><p>It is indeed slow pace. Slowly phasing out the flop biomaterial (Trabecular Metal), while testing & securing the newer advanced biomaterial Si3N4 remotely! Smart move by Zimmer![/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6011765"]Below, just a few excerpts from a long list is to answer the above quotes: [LIST] [*]The [B]stock weakness[/B] gives legitimacy to the [B]contrived negative blogs[/B]. The idea is to [B]create fear and uncertainty among investors[/B] by making [B]all news events appear to be negatives[/B] and to [B]fabricate new issues[/B] that the shorts hope will [B][COLOR=#ff0000]demoralize investors[/COLOR][/B]. [/LIST] [LIST] [*]There are a number of bloggers who participate in these attacks. Many of these bloggers appear to work together and [B]coordinate their negative attacks[/B]. It is striking that many of [B]these people have connections to one another[/B]. Many of them were trained at a well-known blogging site that was founded by hedge fund people. [/LIST] [LIST] [*]The situation quickly escalated. In the rebuttal, the blogger [B][COLOR=#ff0000]accused[/COLOR][/B] me of being stupid, [B]deceitful and [COLOR=#ff0000]being paid by the Company[/COLOR] to write positive comments[/B]. [/LIST] [LIST] [*]The blogger was [B]indifferent to truth and actually would make up information that was factually incorrect[/B]. When made aware that the information was wrong, he/she would[B] ignore it and even repeat it in later blogs[/B]. [/LIST] From here: [URL]https://smithonstocks.com/illegal-naked-short-selling-appears-to-lie-at-the-heart-of-an-extensive-stock-manipulation-scheme/[/URL] [URL]http://counterfeitingstock.com/CounterfeitingStock.html[/URL] Know their methods: Blame the Management! Attack the stock! Attack the FACT poster; the researcher (Boston), trying to discredit his hard work! Trying to MUTE him! Because he is threatening their interests! Spread negative misinformation about the tiny company (Amedica)... with superior technologies that being bought out soon by a bigger medical device company (Zimmer)...based on so many pieces of evidence. etc... Now, to answer the quotes regarding, personnel & product development connections: [QUOTE="anonymous,...]Currently, a few Zimmer VPs at Amedica: [URL]https://www.linkedin.com/in/ryanjlong/[/URL] [URL]https://www.linkedin.com/in/jamey-rottman/[/URL] [URL]https://www.linkedin.com/in/dana-lyons-a23b9550/[/URL][/QUOTE] [QUOTE="anonymous,...]The Board of Directors of [B]Orthopaedic Synergy, Inc[/B]. ("OSI") whose subsidiary companies include [B]OMNIlife science[/B]®, Inc., Enztec, Ltd., and Praxim, SA, have elected two experienced directors to their Board. [B]Guy Mayer,[/B] [URL='https://www.prnewswire.com/news-releases/orthopaedic-synergy-inc-announces-key-additions-to-the-board-of-directors-208198531.html']https://www.prnewswire.com/news-rel...ions-to-the-board-of-directors-208198531.html[/URL] President of the Orthopedics Implant Division - [URL='https://www.zoominfo.com/c/zimmer-inc/43303663']Zimmer Inc[/URL] [URL]https://www.zoominfo.com/p/Guy-Mayer/382663[/URL] Late December 2013 - Early 2014, OSI helped them to design [B]prototype of femoral heads[/B] to initiate the [B]biomechanical testing with a strategic partne[/B]r Per below blog, even Amedica Spine Fusion CASCADE clinical trial was supervised by Zimmer Surgeons: [URL]https://amedicablog.wordpress.com/2017/09/12/zimmer-amedica-connections-via-personnel/[/URL] [/QUOTE] In addition to personnel & product development connections, [B]Zimmer & Amedica[/B] have [B]connections via business partners[/B] as well: [URL]https://seekingalpha.com/article/4110015-amedica-amda-presents-ladenburg-thalmann-2017-healthcare-conference-slideshow[/URL] On slide 27/30, NGK billion-dollar company partner with Amedica and: [URL]http://www.jmdm.co.jp/eng/corporate/partners[/URL] and...From NGK & Japan Medical Dynamic Marketing Inc business alliance: [INDENT]Notice of Capital and [B]Business Alliance with Japan Medical Dynamic Marketing Inc. and Acquisition of Stock Shares[/B] (Equity Method Affiliate)[/INDENT] [URL]https://www.ngkntk.co.jp/english/news/upload/20160420_e.pdf[/URL] and....since 2009, Zimmer & JMDM are parnters! [INDENT]In [B]November 2009[/B], we concluded a [B]joint sales agreement with Zimmer K.K[/B]. to further strengthen our product lineup and promote joint sales, thus expanding our market share at the same time.[/INDENT] [URL]http://www.jmdm.co.jp/eng/products[/URL] Furthermore, [INDENT]On [B]September 22, 2017, Zimmer Biomet G.K[/B]. (the “Borrower”), a wholly-owned subsidiary of Zimmer Biomet Holdings, Inc. (the “Company”), entered into (i) a [B]Term Loan Agreement[/B] (the “New Term Loan Agreement”) with [B]Sumitomo Mitsui Banking Corporation (“SMBC”), for a new [COLOR=#ff0000]¥21.3 billion[/COLOR] term loan[/B],[/INDENT] [URL]https://www.sec.gov/Archives/edgar/data/1136869/000119312517297866/d464265d8k.htm[/URL] The loan amount is around $189 millions USD. What is cooking in Japan? Why such a big loan? Some forms of business preparations to profit in Japan Market! Coincidentally, or jointly planned, whatever you put it, Amedica's latest business update: [B][/B] [INDENT][B]Progress toward regulatory clearance in [COLOR=#ff0000]Japan[/COLOR][/B]. [/INDENT] [URL]https://investors.amedica.com/press-releases/detail/113/amedica-provides-business-update[/URL] & Even new Spine HQ: [URL]http://ozarch.com/2017/10/zimmer-biomet-spine-opens-new-headquarters-westminster-colorado/[/URL] Amedica has mature Spine products & other products are being developed too. See all the clicks between both? [B]Zimmer Spine business has tons of room to grow, ranking #5 in the industry[/B] (look at page 25): [URL]https://www.sec.gov/Archives/edgar/data/1136869/000119312517065632/d285470d10k.htm[/URL] and the [B]job openings at the new Spine HQ[/B] (expanding): [URL]https://www.indeed.com/jobs?q=Zimmer+Biomet&rbl=Westminster,+CO&jlid=6f64b78298d21bb1[/URL] & Of course... Most importantly, Zimmer's CEO [B]Hanson's own words[/B]: [INDENT]"In terms of our innovation capabilities, [B]Zimmer Biomet[/B] is [B][COLOR=#ff0000]uniquely positioned to leverage platform technologies[/COLOR][/B] across our entire portfolio, including [B][COLOR=#ff0000]advanced proprietary materials[/COLOR][/B] and surgical robotics applications. As a company, we plan to build on this foundation. We will have an [B]unwavering emphasis[/B] on [B][COLOR=#ff0000]patient safety and quality excellence[/COLOR][/B], creating an engaged and innovative workplace and working to position the company to deliver [B][COLOR=#ff0000]top quartile total shareholder returns.[/COLOR][/B]" "That said, based on everything I've learned, [B]I am more [COLOR=#ff0000]confident than ever[/COLOR] that this business is going to turn around[/B]. Although the [B]pacing may not be what you expected or hoped for[/B], I'm [B][COLOR=#ff0000]100% confident[/COLOR] that the [COLOR=#ff0000]end game[/COLOR][/B] is going to be something you're [B][COLOR=#ff0000]going to be very happy[/COLOR][/B] about. So thanks so much. I appreciate you joining the call today. I'm looking forward [B]to connecting with you between now and earnings call[/B], I’m sure, [B][COLOR=#ff0000]through various events[/COLOR][/B], but really looking forward to connecting on the [B][COLOR=#ff0000]first quarter earnings call[/COLOR][/B] as we [B][COLOR=#ff0000]give guidance for 2018[/COLOR][/B]. Thanks so much." [URL]https://seekingalpha.com/article/4141232-zimmer-biomets-zbh-ceo-bryan-hanson-q4-2017-results-earnings-call-transcript?part=single[/URL] [/INDENT] It is indeed slow pace. Slowly phasing out the flop biomaterial (Trabecular Metal), while testing & securing the newer advanced biomaterial Si3N4 remotely! Smart move by Zimmer![/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
Zimmer
>
Amedica and Zimmer soon to be one
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
Zimmer
>
Amedica and Zimmer soon to be one
>